PCG
EDIT icon

Private Capital Group’s Editas Medicine EDIT Stock Holding History

Private Capital Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$5K Sell
396
-13
-3% -$174 ﹤0.01% 1249
2022
Q1 		$8K Buy
+409
New +$7.6K ﹤0.01% 1344
2021
Q4 		– Sell
-43
Closed -$2K – 2103
2021
Q3 		$2K Buy
43
+27
+169% +$1.48K ﹤0.01% 1845
2021
Q2 		$1K Buy
16
+10
+167% +$369 ﹤0.01% 1955
2021
Q1 		$0 Buy
+6
New +$342 ﹤0.01% 2076

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Private Capital Group's EDIT Position: Q2 2022 in Review

Private Capital Group reduced its Editas Medicine (EDIT) stake by 3.2% in Q2 2022, selling an estimated $174 and leaving 396 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

Private Capital Group first reported a position in EDIT in Q1 2021 and has held it in 5 quarters since. The position peaked at $8K in Q1 2022. 257 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • Private Capital Group held 396 shares of Editas Medicine worth $5K as of Q2 2022.
  • Private Capital Group sold 13 Editas Medicine shares in Q2 2022, an estimated $174.
  • Editas Medicine made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1249 holding.
  • Private Capital Group first reported a position in Editas Medicine in Q1 2021 and has held it in 5 quarters since.
  • Private Capital Group's Editas Medicine position peaked at $8K in Q1 2022.
  • 257 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.